Unraveling the fertility knot in World Health Organization type 2 anovulatory women Another step toward a pharmacogenetic treatment choice

Reflections on “FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility” by Valkenburg et al.

Authors

Manuela Simoni, M.D., Ph.D.

Volume 103, Issue 4, Pages 900-901

Abstract

Reflections on “FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility” by Valkenburg et al.

Read the full text at: http://www.fertstert.org/article/S0015-0282(15)00085-0/fulltext